Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses

Journal of Health Economics and Outcomes Research
John E SchneiderIvana Stojanovic

Abstract

Studies have shown that improvements in glycemic control are associated with avoidance or delayed onset of diabetes complications, improvements in health-related quality of life, and reductions in diabetes-related health care costs. Clinical practice guidelines recommend maintaining a hemoglobin A1c (HbA1c) level less than 7%, but among type 2 diabetes patients using insulin, two-thirds have HbA1c above 7% and one-third have HbA1c above 9%. This study examined the use of insulin management services to enable patients to optimize insulin dosing to achieve HbA1c targets and subsequently reduce health care costs. Cost savings may be achieved through reduced complications and hospitalizations, as well as reduced outpatient, physician, and clinic costs. This study quantified the reduction in pharmaceutical expenses related to the use of an enhanced insulin management service to improve glycemic control. Two hundred seventeen insulin-reliant patients were enrolled in the d-Nav® Insulin Guidance Service through a participating insurance group. A prospective cost analysis was conducted using data from enrolled patients who completed the first 90 days of follow up. Of the 192 patients who completed the 90-day study period, 54 (28.13%) w...Continue Reading

References

Dec 24, 2004·Diabetes Care·Todd P GilmerLeif I Solberg
Jun 30, 2007·Current Opinion in Critical Care·Juan Jose Blondet, Greg J Beilman
Sep 19, 2007·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Efficacy Assessment Subcommittee of the American College of Physicians
Dec 24, 2010·Diabetes Technology & Therapeutics·Eran BashanIsrael Hodish
Jul 8, 2011·Research in Social & Administrative Pharmacy : RSAP·Rahul JainWinston Wong
Aug 23, 2011·Journal of Medical Economics·Carrie FidlerSamantha Gillard
Apr 24, 2012·Journal of Diabetes and Its Complications·Eran Bashan, Israel Hodish
Dec 12, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Meryl BrodDonald M Bushnell
Dec 30, 2014·Journal of Diabetes and Its Complications·Dragana Lovre, Vivian Fonseca
Aug 2, 2015·BMJ Case Reports·Eran BashanIsrael Hodish
Nov 10, 2015·Postgraduate Medicine·Charles F Shaefer, John Anderson
Jan 2, 2016·Diabetes Care·Elizabeth SelvinRichard M Bergenstal
Jun 12, 2016·Journal of Diabetes and Its Complications·R HarperI Hodish
Jul 13, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·William Green, Matthew Taylor
Mar 23, 2017·Diabetes Research and Clinical Practice·Melinda J CarringtonJoshua F Wiley
Jul 26, 2017·Current Diabetes Reports·Laura N McEwenWilliam H Herman

❮ Previous
Next ❯

Citations

Apr 24, 2018·Clinical Diabetes and Endocrinology·I Hodish

❮ Previous
Next ❯

Software Mentioned

Nav
Excel

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.